Login
Communauté Vinci
Extérieur
Si votre nom d'utilisateur ne se termine pas par @vinci.be ou @student.vinci.be, utilisez le formulaire ci-dessous pour accéder à votre compte de lecteur.
Titre : | Postrehabilitation Functional Improvements in Patients With Inflammatory Myopathies: The Results of a Randomized Controlled Trial (2017) |
Auteurs : | Vincent Tiffreau ; François Rannou ; François Kopciuch |
Type de document : | Article |
Dans : | Archives of Physical Medicine and Rehabilitation (2017/2, 2017) |
Article en page(s) : | pp. 227-234 |
Langues: | Anglais |
Descripteurs : |
HE Vinci Myosite ; Qualité de vie ; Rééducation et réadaptation |
Mots-clés: | Myositis ; Quality of life |
Résumé : |
Objective To evaluate the medium-term functional effect and the effect on quality of life of a standardized rehabilitation program in patients with inflammatory myopathies (IMs). Design A multicenter, randomized controlled trial. Setting Four university hospitals. Participants Patients (N=21) with polymyositis. Interventions The intervention group participated in a 4-week standardized, hospital-based rehabilitation program followed by a personalized, self-managed, home-based rehabilitation program. The control group received physiotherapy on an outpatient basis. Study participants were evaluated at inclusion, at the end of the rehabilitation program (1mo), and then at 6 and 12 months. Main Outcome Measures The primary efficacy criterion was the Health Assessment Questionnaire Disability Index (HAQ-DI), and the secondary criteria were quality of life (according to the Medical Outcomes Study 36-Item Short-Form Health Survey [SF-36] questionnaire), muscle performance (isokinetic strength, Motor Function Measure, and Kendall Manual Muscle Test), gait, pain, fatigue, and biomarkers of tolerance and disease activity. Results At 12 months, the mean + SD HAQ-DI was significantly lower in the intervention group than in the control group (.64+.53 vs 1.36+1.02; P=.026). The intervention group also had better scores than the control group for some quality-of-life dimensions (SF-36 General Health: 53.44+8.73 vs 36.57+22.10, respectively; P=.038; SF-36 Role Physical: 63.89+43.50 vs 17.86+37.40, respectively; P=.023) and pain levels (5.0+10.61 vs 33.38+35.68, respectively; P=.04) at 12 months. The program was well tolerated by all the participants. Conclusions In patients with IMs, the combination of a 4-week standardized rehabilitation program and a personalized, home-based, self-managed rehabilitation program was well tolerated and had a positive medium-term functional effect. |
Disponible en ligne : | Oui |
En ligne : | https://login.ezproxy.vinci.be/login?url=https://www.sciencedirect.com/science/article/pii/S0003999316311637 |